Competition Government Healthcare Healthcare Provider 
MedCity News
NOVEMBER 26, 2023
While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.
Scott’s Directories
OCTOBER 19, 2022
One of the most competitive industries in the United States is healthcare. government reveal that in 2019, spending on healthcare increased to about $3.8 But despite the success recorded in the healthcare industry, it’s often tough for many B2B healthcare marketers to get into. Statistics from the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarify Health
DECEMBER 21, 2021
The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. According to the federal government, out-of-network surprise billing occurs 10 million times a year. Let’s take a closer look at each one and how they will impact health plans.
PM360
JUNE 26, 2023
This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation.
Referral MD
MAY 4, 2022
The need to attract new patients through digital means is forcing healthcare into a new era of on-demand patient consumerism. The development of new platforms and technologies drive healthcare organizations to adapt in an effort to give consumers of our services exactly what they want. What do they want?
Contrarian Sales Techniques
FEBRUARY 21, 2023
Pharmaceutical sales representatives play a crucial role in the healthcare industry , even though they cannot provide direct advice on medicines or medical devices. By educating providers about the benefits of new drugs and medical devices, they can help to improve patient outcomes and reduce the overall burden of disease.
Pharmaceutical Technology
OCTOBER 5, 2022
Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.
Expert insights. Personalized for you.
76 
Let's personalize your content